Leprosy Mailing List – January 5, 2021
Ref.: (LML) New publications on leprosy. January 2021
From: Annemiek Akerboom, Amsterdam, the Netherlands
__________________________________________________________________________________
Dear colleagues,
Infolep wishes you a healthy, joyful and prosperous new year!
Many of us look back at a challenging year. A year in which we faced uncertainty, fear, restrictions and losses. But 2020 has also shown us that we are resilient, innovative and cooperative. A lot of research has been conducted on leprosy and COVID-19 and beautiful initiatives emerged to support each other and especially marginalized populations. A crisis like the COVID-19 pandemic disproportionally affects marginalized individuals, such as people affected by leprosy, and more clearly exposed the impact of stigma. We truly hope 2021 will be the year in which we will build back better.
This new year kick-starts with an exciting month, as we will celebrate World Leprosy Day on 30 January and the WHO will launch the NTD Roadmap on 28 January.
Below you will find the list with new publications on leprosy and interesting events. Feel free to contact me to receive full-text versions if these cannot be found through the Infolep portal. Also, I would be happy to assist you with literature searches.
Thank you for your interest and support in 2020. We look forward to best serve your information needs and collectively work towards a world without leprosy in the coming years.
Warm regards,
Anniek Akerboom
Infolep Coordinator
www.leprosy-information.org
a.akerboom@infolep.org
Highlighted
World Leprosy Day
31 Jan 2021
Learn more
Interim Advice on the use of Rifampicin for post-exposure prophylaxis (PEP), in light of recent information on nitrosamine impurities in rifampicin
ILEP Technical Commission. 2020;
Learn more
Thirteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases, 15–17 September 2020
World Health Organization. 2020;
Learn more
Leprosy & COVID-19
Severe Type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences.
Saxena S, Khurana A, B S, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;
Learn more
New publications
The adverse drug effects of dapsone therapy in leprosy: a systematic review
Hilder R, Lockwood D. Leprosy review. Lepra. 2020; 91 (3) : 232-243.
Learn more
Hansen's Disease: differences in clinical presentation among Latin American and South East Asian born patients identified in Los Angeles County, California (1995–2016)
Croker C, Phommasith J, Jerskey R, et al. Leprosy review. Lepra. 2020; 91 (3) : 244-254.
Learn more
Leprosy in a prison population: A new active search strategy and a prospective clinical analysis.
Filho F, Santana J, de Almeida R, et al. PLoS neglected tropical diseases. 2020; 14 (12) : e0008917.
Learn more
Assessing the prospect of a common health-related stigma reduction response: Cross-perspectives of people living with stigmatised health conditions in Indonesia.
Rai S, Syurina E, Peters R, et al. Global public health. 2020;
Learn more
Leprosy post-exposure prophylaxis: innovation and precision public health.
Moraes M, Düppre N. The Lancet. Global health. 2021; 9 (1) : e8-e9.
Learn more
Why can't we control Morbus Hansen?
Naafs B. info Hansen. 2020;
Learn more
Polymorphisms in mitochondrial ribosomal protein S5 (MRPS5) are associated with leprosy risk in Chinese.
Xing Y, He J, Wen Y, et al. PLoS neglected tropical diseases. 2020; 14 (12) : e0008883.
Learn more
Single-Nucleotide Polymorphisms in Genes Predisposing to Leprosy in Leprosy Household Contacts in Zhejiang Province, China
Shen Y, Long S, Kong W, et al. Pharmacogenomics and Personalized Medicine. Informa UK Limited. 2020;
Learn more
Analysis of the Myeloid-Derived Suppressor Cells and Annexin A1 in Multibacillary Leprosy and Reactional Episodes
Damazo AS, Silva SFD, Cavalcante LRDS, et al. Research Square. 2020;
Learn more
Misdiagnosis of leprosy in Brazil in the period 2003 - 2017: spatial pattern and associated factors.
Neves K, Nobre M, Machado L, et al. Acta tropica. 2020;
Learn more
The Dermlep Study Part 2: Results of a Nation-Wide Survey of Dermatologists' Access to Quality Leprosy Services at their Clinics and Hospitals in India.
Rao NP, Rathod S, Suneetha S, et al. Indian dermatology online journal. 2020; 11 (6) : 895-903.
Learn more
Gandhi's Evolving Discourse on Leprosy
Kakar S. Palgrave Studies in the History of the Media. Springer International Publishing. 2020;
Learn more
Relationship between Plantar Pressure and Sensory Disturbance in Patients with Hansen's Disease-Preliminary Research and Review of the Literature.
Tashiro S, Gotou N, Oku Y, et al. Sensors (Basel, Switzerland). 2020;
Learn more
Synthetic Phenolic Glycolipids for application in diagnostic tests for leprosy.
van Dijk HJ, van Hooij A, Groot ML, et al. Chembiochem : a European journal of chemical biology. 2020;
Learn more
Functional biomarker signatures of circulating T-cells and its association with distinct clinical status of leprosy patients and their respective household contacts.
Marçal P, Gama R, de Oliveira L, et al. Infectious diseases of poverty. 2020; 9 (1) : 167.
Learn more
Why do Leprosy patients default treatment; Evidence from Sri Lanka
Arnold M. International Journal of Progressive Sciences and Technologies. 2020; 23 (2) : 654-659.
Learn more
HARP: a database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae.
Vedithi S, Malhotra S, Skwark M, et al. Computational and structural biotechnology journal. 2020;
Learn more
Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
Cruz R, Bührer-Sékula S, Penna G, et al. Anais brasileiros de dermatologia. 2018; 93 (3) : 377-384.
Learn more
Effectiveness of the retreatment of patients with multibacillary leprosy and episodes of erythema nodosum leprosum and/or persistent neuritis: a single-center experience.
Lastória J, Putinatti M, de Almeida T, et al. Anais brasileiros de dermatologia. 2018; 93 (2) : 181-184.
Learn more
Endocrinological Testicular Dysfunction in Patients with Lepromatous Leprosy and the Impact of Disease on Patient's Quality of Life.
Mohta A, Agrawal A, Sharma P, et al. Indian dermatology online journal. 2020; 11 (6) : 959-964.
Learn more
Hanseniasis in the municipality of Western Amazon (Acre, Brazil): are we far from the goal of the World Health Organization?: Hansen and Western Amazon.
Araújo F, Abreu L, Laporta G, et al. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2020;
Learn more
Epidemiological profile and tendency of leprosy in people younger than 15 years.
Santos Á, Costa A, de Souza J, et al. Revista da Escola de Enfermagem da U S P. 2020;
Learn more
Risk Factors Related to the Events of Leprosy in Children age 5-14 Years in City of Sorong West Papua
Maryen Y, Parlaungan J, Samaran E, et al. Medico Legal Update. 2020; 20 (4) : 2160-2167.
Learn more
Spectrum of Inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India.
Yadav R, Dalvi A, Gupta M, et al. Scandinavian journal of immunology. 2020;
Learn more
Empowerment Based on Collaborative Governance in Leprosy Patients In Central Java
Imam Al Hafis R, Larasati E, Warsono H, et al. 6th International Conference on Social and Political Sciences (ICOSAPS 2020). 2020;
Learn more
La influencia del poder colonial sobre la población y la naturaleza determinaron los asentamientos de la enfermedad de Hansen en Surinam.
Menke H, Pieters T, Menke J. Revista de Leprología. 2020; 32 (6) : 411-439.
Learn more
Porcentajes variables de casos de lepra paucibacilar en la notificación global de casos de lepra.
Butlin R, Lockwood DNJ. Revista de Leprología. 2020; 32 (6) : 441-449.
Learn more
Interesting events
ISNTD Connect Webinar: Disease management, disability and inclusion: disability inclusion to achieve the NTD Roadmap targets
03 Dec 2020 | Recording
Watch it here
ISNTD Connect Webinar: Health Technologies for NTDs: Accelerating Research & Development for Impact
17 Dec 2020 | Recording
Watch it here
Sasakawa Health Foundation's Webinar Series 'Issues in Leprosy amid the Coronavirus Pandemic':
- 12 Dec 2020 | Recording: Hansen's Disease Medical Care in Brazil Today (Portuguese and Japanese only)
- 22 Jan 2021 | Details will be provided in due course
WHO NTD Roadmap launch
28 Jan 2021 | Online
The link to register will be provided soon
World NTD Day
30 Jan 2021
World Leprosy Day in India
30 Jan 2021
World Leprosy Day
31 Jan 2021
Websites & Services
Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
https://www.infohansen.org/
ALLF - Official website of the Association des Léprologues de Langue Française
https://allf.medicalistes.fr/
LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in this theme to share ideas, information, experiences, and questions.
https://groups.google.com/forum/#!forum/leprosymailinglist
InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)
https://www.infontd.org/
Newsletters & Journals
ILEP newsletter archive: ilepfederation.org/news-events/#archive
GPZL newsletter archive: zeroleprosy.org/newsletter-archive
Hansenologia Internationalis: www.ilsl.br/revista/atual.php
Indian Journal of Leprosy: www.ijl.org.in/index.html
Leprosy Review: leprosyreview.org
Leprosy Review Repository (1928-2001): leprev.ilsl.br/arquivo.php
Fontilles Revista de Leprología: www.leprosy-information.org/resource/revista-de-leprologia
GDPR & the Infolep newsletter
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regard to the GDPR, including our privacy statement and mailing list. Infolep sends out monthly e-mails to its subscribers with an overview of recent publications on leprosy. The purpose of this activity is to keep subscribers up to date. Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else. We hope the content from the Infolep newsletter is useful to you, but you can update your preferences or unsubscribe from this list at any time.
Copyright © 2020 Infolep, All rights reserved.
You are receiving this mail because you opted in at our website
Our mailing address is:
Infolep
Wibautstraat 137-k
Amsterdam, 1097 DN
Netherlands
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list
______________________________________________________________________________________
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
--You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/5d948d4a-c5d0-4e77-875d-3a5b4d7615f6n%40googlegroups.com.
No comments:
Post a Comment